LINC02287

Across TCGA pan-cancer cohorts, LINC02287 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of LINC02287’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where LINC02287 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02287 is over-expressed in tumor, although a few such as BLCA and ESCA show the opposite, repressed pattern.

BLCA, HNSC, and ESCA are the cancer types where LINC02287 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02287 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	III,IV	−0.217	.003	8	view →
HNSC	Female	II,III,IV	+0.023	.015	6	view →
ESCA	All	All	−0.250	.019	2	view →
READ	All	All	−0.188	.004	2	view →
COAD	Female	II,III,IV	−0.109	<.001	2	view →
KICH	All	All	−0.066	.019	1	view →
KIRC	All	All	−0.025	.036	1	view →
THCA	Male	All	−0.013	.035	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

LINC02287–BLCA

Open the BLCA breakdown →